Prostate Cancer - Results from #80

REVIEW UroToday

UBE2J1 Is the E2 Ubiquitin-Conjugating Enzyme Regulating Androgen Receptor Degradation and Antiandrogen Resistance - Beyond the Abstract March 28, 2024

Critical Evaluation of Artificial Intelligence as a Digital Twin of Pathologists for Prostate Cancer Pathology - Beyond the Abstract March 26, 2024

Novel Hormone Therapy and Coordination of Care in High-Risk Biochemically Recurrent Prostate Cancer - Beyond the Abstract March 12, 2024

Addition of Cribriform Pattern 4 and Intraductal Prostatic Carcinoma into the CAPRA-S Tool Improves Post-Radical Prostatectomy Patient Stratification in a Multi-Institutional Cohort - Beyond the Abstract March 7, 2024

PARP Inhibitors Have Comparable Efficacy with Platinum Chemotherapy in Patients with BRCA-positive Metastatic Castration-resistant Prostate Cancer. A Systematic Review and Meta-analysis - Beyond the Abstract March 4, 2024

The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies - Beyond the Abstract March 4, 2024

Genetic and Biological Drivers of Prostate Cancer Disparities in Black Men - Beyond the Abstract February 29, 2024

Biochemical Recurrence in Patients with Prostate Cancer after Primary Definitive Therapy: Next-Generation Imaging and Treatment Based on Risk Stratification - Beyond the Abstract February 29, 2024

Prostate Cancer Disparities in Metastatic and Treatment Status for Hispanic Americans Based on Country of Origin Compared to Non-Hispanic Whites Using the National Cancer Database - Beyond the Abstract February 27, 2024

The Brazilian National Prospective Active Surveillance (AS) Cohort of Patients with Low-Risk Prostate Cancer in the Public Health System: vigiaSUS Study Protocol - Beyond the Abstract February 23, 2024

Prehabilitative Versus Rehabilitative Exercise in Prostate Cancer Patients Undergoing Prostatectomy - Beyond the Abstract February 21, 2024

Cancer Origin Tracing and Timing in Two High-Risk Prostate Cancers Using Multisample Whole Genome Analysis: Prospects for Personalized Medicine - Beyond the Abstract February 14, 2024

Quality Rectal Hydrogel Placement Allows for Gel-Enabled Dose-Escalated EBRT (GEDE-EBRT) Without Rectal Interference in Prostate Cancer - Beyond the Abstract February 14, 2024

MYC Is a Regulator of Androgen Receptor Inhibition-Induced Metabolic Requirements in Prostate Cancer - Beyond the Abstract February 7, 2024

Comparative Analysis of Robot-Assisted and Open Approach for PSMA-Radioguided Surgery in Recurrent Prostate Cancer - Beyond the Abstract February 1, 2024

An International Multi-Institutional Validation Study of the Algorithm for Prostate Cancer Detection and Gleason Grading - Beyond the Abstract January 22, 2024

Active Surveillance Should Not Be Routinely Considered in ISUP Grade Group 2 Prostate Cancer - Beyond the Abstract January 18, 2024

Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer - Beyond the Abstract January 12, 2024

Therapy with Metronomic Cyclophosphamide for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer - Beyond the Abstract January 11, 2024

Long-Term Outcomes Following Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy in High-Risk Prostate Cancer: Update from the FASTR/FASTR-2 Trials - Beyond the Abstract January 11, 2024

Page 5 of 57